Should clinicians worry about vancomycin-resistant Enterococcus bloodstream infections?
| Autor: | C D Salgado, Michael G. Ison |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Transplantation
education.field_of_study medicine.medical_specialty biology business.industry media_common.quotation_subject Population Retrospective cohort study Hematology biochemical phenomena metabolism and nutrition bacterial infections and mycoses biology.organism_classification medicine.disease_cause Enterococcus Medicine Clinical significance Vancomycin-resistant Enterococcus Worry business education Intensive care medicine media_common |
| Zdroj: | Bone Marrow Transplantation. 38:771-774 |
| ISSN: | 1476-5365 0268-3369 |
| DOI: | 10.1038/sj.bmt.1705532 |
| Popis: | The clinical significance of vancomycin-resistant Enterococcus (VRE) infections has been debated for many years. An article in this issue of the journal by Dubberke and co-workers (Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?) addresses this question. This is a retrospective cohort study of patients with hematologic malignancies and recipients of hematopoietic stem cell transplant (HSCT) who developed nosocomial VRE bloodstream infections (BSIs) over the course of almost 7 years at Barnes-Jewish Hospital. Data regarding VRE infections in this highly immunosuppressed population has been sparse,1, 2 and this paper, reporting the characteristics and outcomes of 60 patients who suffered 68 VRE BSIs, represents the largest published series of VRE BSIs in this population to date.3 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|